SCIENTIFIC EVIDENCE
Dual-Pronged Lipid Nanocarriers Promote Immunotherapy for TNBC by Inducing Immunogenic Cell Death and Activating Lymphoid Immune Cells.
Research (Washington, D.C.)
Ye J, Wang S, Wu S, Li R, Li X, Chen S, Wang Y, Wang L, Qin C, Wang H, Yang Y, Wang J, Du T, Ma F, Liu Y.
